Explore comprehensive CDMO services offered by Samsung Biologics, supporting end-to-end Anlaytical Testing, Drug Development and Manufacturing. Samsung Biologics enables faster, compliant, and scalable pharma innovation tailored to your needs.
Country: South Korea
Description: Samsung Biologics is a South Korean company that is a global Contract Development and Manufacturing Organization (CDMO) for biopharmaceuticals, providing a full range of services from cell line development to aseptic fill-finish. Founded in 2011 and headquartered in Incheon, it manufactures products for other biopharmaceutical companies and has the world's largest biomanufacturing capacity. The company also develops and commercializes biosimilars and other biopharmaceutical products.
